<VariationArchive VariationID="1526169" VariationName="NM_032520.5(GNPTG):c.638_639del (p.Leu212_Phe213insTer)" VariationType="Deletion" Accession="VCV001526169" Version="4" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-02-20" DateCreated="2022-04-02" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1517573" VariationID="1526169">
      <GeneList>
        <Gene Symbol="GNPTG" FullName="N-acetylglucosamine-1-phosphate transferase subunit gamma" GeneID="84572" HGNC_ID="HGNC:23026" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16p13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="1351931" stop="1364113" display_start="1351931" display_stop="1364113" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="1401899" stop="1413351" display_start="1401899" display_stop="1413351" Strand="+" />
          </Location>
          <OMIM>607838</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_032520.5(GNPTG):c.638_639del (p.Leu212_Phe213insTer)</Name>
      <CanonicalSPDI>NC_000016.10:1362635:TTTTT:TTT</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>16p13.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="1362636" stop="1362637" display_start="1362636" display_stop="1362637" variantLength="2" positionVCF="1362635" referenceAlleleVCF="CTT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="1412637" stop="1412638" display_start="1412637" display_stop="1412638" variantLength="2" positionVCF="1412636" referenceAlleleVCF="CTT" alternateAlleleVCF="C" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.1362639_1362640del" Assembly="GRCh38">
            <Expression>NC_000016.10:g.1362639_1362640del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.1412640_1412641del" Assembly="GRCh37">
            <Expression>NC_000016.9:g.1412640_1412641del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016985.1" sequenceAccession="NG_016985" sequenceVersion="1" change="g.15741_15742del">
            <Expression>NG_016985.1:g.15741_15742del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_033129.1" sequenceAccession="NG_033129" sequenceVersion="1" change="g.57068_57069del">
            <Expression>NG_033129.1:g.57068_57069del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_032520.5" sequenceAccession="NM_032520" sequenceVersion="5" change="c.638_639del" MANESelect="true">
            <Expression>NM_032520.5:c.638_639del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_115909.1" sequenceAccession="NP_115909" sequenceVersion="1" change="p.Leu212_Phe213insTer">
            <Expression>NP_115909.1:p.Leu212_Phe213insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="193302858" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_032520.5(GNPTG):c.638_639del (p.Leu212_Phe213insTer) AND GNPTG-mucolipidosis" Accession="RCV002052189" Version="1">
        <ClassifiedConditionList TraitSetID="719">
          <ClassifiedCondition DB="MedGen" ID="C1854896">GNPTG-mucolipidosis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-03-22" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_032520.5(GNPTG):c.638_639del (p.Leu212_Phe213insTer) AND not provided" Accession="RCV002550510" Version="2">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-03-22" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-03-22" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2022-04-02" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">19370764</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28950892</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301784</ID>
          <ID Source="BookShelf">NBK24701</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="719" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3219" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">GNPTG-mucolipidosis</ElementValue>
                <XRef ID="MONDO:0009652" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ML III GAMMA</ElementValue>
                <XRef Type="MIM" ID="252605" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ML IIIC</ElementValue>
                <XRef Type="MIM" ID="252605" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MUCOLIPIDOSIS III, COMPLEMENTATION GROUP C</ElementValue>
                <XRef Type="MIM" ID="252605" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MUCOLIPIDOSIS III, IRANIAN VARIANT FORM</ElementValue>
                <XRef Type="MIM" ID="252605" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MUCOLIPIDOSIS III, VARIANT FORM</ElementValue>
                <XRef Type="MIM" ID="252605" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mucolipidosis type III gamma</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17705" />
                <XRef ID="17705" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Mucolipidosis III gamma (ML III?) is a slowly progressive inborn error of metabolism mainly affecting skeletal, joint, and connective tissues. Clinical onset is in early childhood; the progressive course results in severe functional impairment and significant morbidity from chronic pain. Cardiorespiratory complications (restrictive lung disease from thoracic involvement, and thickening and insufficiency of the mitral and aortic valves) are rarely clinically significant. A few (probably &lt;10%) affected individuals display mild cognitive impairment.</Attribute>
                <XRef ID="NBK24701" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301784</ID>
                <ID Source="BookShelf">NBK24701</ID>
              </Citation>
              <XRef ID="423470" DB="Orphanet" />
              <XRef ID="577" DB="Orphanet" />
              <XRef ID="C1854896" DB="MedGen" />
              <XRef ID="MONDO:0009652" DB="MONDO" />
              <XRef Type="MIM" ID="252605" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4538511" SubmissionDate="2022-03-25" DateLastUpdated="2022-04-02" DateCreated="2022-04-02">
        <ClinVarSubmissionID localKey="16-1412636-CTT-C" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002318739" DateUpdated="2022-04-02" DateCreated="2022-04-02" Type="SCV" Version="1" SubmitterName="3billion" OrgID="507830" OrganizationCategory="other" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">28950892</ID>
          </Citation>
          <Comment>Frameshift: predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant.It is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency:0.0000119). The variant has been reported to be in trans with a pathogenic variant as either compound heterozygous or homozygous in at least one similarly affected unrelated individual(PMID: 28950892). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Proband>yes</Proband>
            </Sample>
            <Method>
              <NamePlatform>NovaSeq</NamePlatform>
              <TypePlatform>whole exome sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Homozygote" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001369" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0012385" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0100324" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GNPTG" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_032520.5:c.638_639del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="252605" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11208158</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="6150505" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="5896575|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003461735" DateUpdated="2024-02-20" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">28950892</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19370764</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20301784</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This premature translational stop signal has been observed in individual(s) with mucolipidosis type III gamma (PMID: 28950892). It has also been observed to segregate with disease in related individuals. This variant is present in population databases (rs746271025, gnomAD 0.01%). This sequence change creates a premature translational stop signal (p.Phe213*) in the GNPTG gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GNPTG are known to be pathogenic (PMID: 19370764, 20301784).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GNPTG" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000016.9:g.1412637_1412638del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4538511" TraitType="Disease" MappingType="XRef" MappingValue="252605" MappingRef="OMIM">
        <MedGen CUI="C1854896" Name="GNPTG-mucolipidosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4538511" TraitType="Finding" MappingType="XRef" MappingValue="HP:0100324" MappingRef="HP">
        <MedGen CUI="C0011644" Name="Scleroderma" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6150505" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4538511" TraitType="Finding" MappingType="XRef" MappingValue="HP:0012385" MappingRef="HP">
        <MedGen CUI="C0685409" Name="Camptodactyly" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4538511" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001369" MappingRef="HP">
        <MedGen CUI="C0003864" Name="Arthritis" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

